Efficacy of secukinumab in pediatric patients with moderate to severe plaque psoriasis: A randomized study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Secukinumab effectively treats moderate to severe pediatric psoriasis, significantly improving skin clearance and quality of life compared to traditional therapies. This interleukin-17A inhibitor shows promise for young patients in China.
Area Of Science
- Dermatology
- Immunology
- Pediatric Medicine
Background
- Secukinumab, an IL-17A inhibitor, is approved for pediatric psoriasis in the EU and US, but not China.
- Psoriasis affects children, impacting their quality of life.
- Evaluating novel biologic therapies for pediatric psoriasis is crucial.
Purpose Of The Study
- To assess the clinical efficacy and safety of secukinumab in Chinese pediatric patients with moderate to severe plaque psoriasis.
- To compare secukinumab with conventional non-biologic therapy.
Main Methods
- A randomized, single-center study involving 33 pediatric patients (6-17 years).
- Treatment arms included secukinumab and conventional non-biologic therapy.
- Primary outcomes: BSA, PASI 75/90/100, IGA 0/1, DLQI, and adverse events.
Main Results
- Secukinumab significantly reduced BSA and PASI scores versus conventional therapy.
- Higher rates of IGA 0/1, DLQI improvement, and PASI 90 response observed with secukinumab.
- No significant dose-dependent differences between 150mg and 300mg secukinumab.
Conclusions
- Secukinumab demonstrates therapeutic efficacy and safety in Chinese pediatric patients with moderate to severe plaque psoriasis.
- The findings support secukinumab as a potential treatment option for this population.
- Further research may explore long-term outcomes and comparative effectiveness.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...